Medindia LOGIN REGISTER
Medindia

Demecarium Interaction with other Drugs


Demecarium is a parasympathomimetic agent, prescribed for glaucoma.

Demecarium Interaction with 149 drugs. Find out more in the list below:

Acebutolol


Demecarium may increase the bradycardic activities of Acebutolol.

Acetylcholine


The risk or severity of adverse effects can be increased when Demecarium is combined with Acetylcholine.

Acetylcholine Chloride


The risk or severity of adverse effects can be increased when Demecarium is combined with Acetylcholine.

Advertisement

Aclidinium


The therapeutic efficacy of Aclidinium can be decreased when used in combination with Demecarium.

Alclometasone


The risk or severity of adverse effects can be increased when Alclometasone is combined with Demecarium.

Aldosterone


The risk or severity of adverse effects can be increased when Aldosterone is combined with Demecarium.

Advertisement

Alprenolol


Demecarium may increase the bradycardic activities of Alprenolol.

Amcinonide


The risk or severity of adverse effects can be increased when Amcinonide is combined with Demecarium.

Androstenedione


The risk or severity of adverse effects can be increased when Androstenedione is combined with Demecarium.

Advertisement

Atenolol


Demecarium may increase the bradycardic activities of Atenolol.

Atracurium


The therapeutic efficacy of Atracurium can be decreased when used in combination with Demecarium.

Atracurium Besylate


The therapeutic efficacy of Atracurium besylate can be decreased when used in combination with Demecarium.

Atropine


The therapeutic efficacy of Atropine can be decreased when used in combination with Demecarium.

Beclomethasone Dipropionate


The risk or severity of adverse effects can be increased when Beclomethasone dipropionate is combined with Demecarium.

Benactyzine


The therapeutic efficacy of Benactyzine can be decreased when used in combination with Demecarium.

Benztropine


The therapeutic efficacy of Benzatropine can be decreased when used in combination with Demecarium.

Betamethasone


The risk or severity of adverse effects can be increased when Betamethasone is combined with Demecarium.

Betaxolol


Demecarium may increase the bradycardic activities of Betaxolol.

Bethanechol


The risk or severity of adverse effects can be increased when Demecarium is combined with Bethanechol.

Biperiden


The therapeutic efficacy of Biperiden can be decreased when used in combination with Demecarium.

Bisoprolol


Demecarium may increase the bradycardic activities of Bisoprolol.

Bopindolol


Demecarium may increase the bradycardic activities of Bopindolol.

Budesonide


The risk or severity of adverse effects can be increased when Budesonide is combined with Demecarium.

Bupranolol


Demecarium may increase the bradycardic activities of Bupranolol.

Butylscopolamine


The therapeutic efficacy of Butylscopolamine can be decreased when used in combination with Demecarium.

Carbachol


The risk or severity of adverse effects can be increased when Demecarium is combined with Carbachol.

Carteolol


Demecarium may increase the bradycardic activities of Carteolol.

Carvedilol


Demecarium may increase the bradycardic activities of Carvedilol.

Celiprolol


Demecarium may increase the bradycardic activities of Celiprolol.

Cevimeline


The risk or severity of adverse effects can be increased when Demecarium is combined with Cevimeline.

Chlorphenoxamine


The therapeutic efficacy of Chlorphenoxamine can be decreased when used in combination with Demecarium.

Ciclesonide


The risk or severity of adverse effects can be increased when Ciclesonide is combined with Demecarium.

Clobetasol


The risk or severity of adverse effects can be increased when Clobetasol is combined with Demecarium.

Clobetasol Propionate


The risk or severity of adverse effects can be increased when Clobetasol propionate is combined with Demecarium.

Clobetasone


The risk or severity of adverse effects can be increased when Clobetasone is combined with Demecarium.

Clocortolone


The risk or severity of adverse effects can be increased when Clocortolone is combined with Demecarium.

Cortisone Acetate


The risk or severity of adverse effects can be increased when Cortisone acetate is combined with Demecarium.

Cyclopentolate


The therapeutic efficacy of Cyclopentolate can be decreased when used in combination with Demecarium.

Darifenacin


The therapeutic efficacy of Darifenacin can be decreased when used in combination with Demecarium.

Deflazacort


The risk or severity of adverse effects can be increased when Deflazacort is combined with Demecarium.

Desloratadine


The therapeutic efficacy of Desloratadine can be decreased when used in combination with Demecarium.

Desonide


The risk or severity of adverse effects can be increased when Desonide is combined with Demecarium.

Desoximetasone


The risk or severity of adverse effects can be increased when Desoximetasone is combined with Demecarium.

Desoxycorticosterone acetate


The risk or severity of adverse effects can be increased when Desoxycorticosterone acetate is combined with Demecarium.

Desoxycorticosterone Pivalate


The risk or severity of adverse effects can be increased when Desoxycorticosterone Pivalate is combined with Demecarium.

Dexamethasone


The risk or severity of adverse effects can be increased when Dexamethasone is combined with Demecarium.

Dexetimide


The therapeutic efficacy of Dexetimide can be decreased when used in combination with Demecarium.

Dicyclomine


The therapeutic efficacy of Dicyclomine can be decreased when used in combination with Demecarium.

Diflorasone


The risk or severity of adverse effects can be increased when Diflorasone is combined with Demecarium.

Diflucortolone


The risk or severity of adverse effects can be increased when Difluocortolone is combined with Demecarium.

Difluprednate


The risk or severity of adverse effects can be increased when Difluprednate is combined with Demecarium.

Dipyridamole


The therapeutic efficacy of Demecarium can be decreased when used in combination with Dipyridamole.

Esmolol


Demecarium may increase the bradycardic activities of Esmolol.

Estrone


The risk or severity of adverse effects can be increased when Estrone is combined with Demecarium.

Fesoterodine


The therapeutic efficacy of Fesoterodine can be decreased when used in combination with Demecarium.

Fludrocortisone


The risk or severity of adverse effects can be increased when Fludrocortisone is combined with Demecarium.

Flumethasone


The risk or severity of adverse effects can be increased when Flumethasone is combined with Demecarium.

Flunisolide


The risk or severity of adverse effects can be increased when Flunisolide is combined with Demecarium.

Flunisolide Anhydrous (obsolete)


The risk or severity of adverse effects can be increased when Flunisolide is combined with Demecarium.

Fluocinolone Acetonide


The risk or severity of adverse effects can be increased when Fluocinolone Acetonide is combined with Demecarium.

Fluocinonide


The risk or severity of adverse effects can be increased when Fluocinonide is combined with Demecarium.

Fluocortolone


The risk or severity of adverse effects can be increased when Fluocortolone is combined with Demecarium.

Fluorometholone


The risk or severity of adverse effects can be increased when Fluorometholone is combined with Demecarium.

FLUPREDNIDENE


The risk or severity of adverse effects can be increased when Fluprednidene is combined with Demecarium.

Fluprednisolone


The risk or severity of adverse effects can be increased when Fluprednisolone is combined with Demecarium.

Flurandrenolide


The risk or severity of adverse effects can be increased when Flurandrenolide is combined with Demecarium.

Fluticasone Furoate


The risk or severity of adverse effects can be increased when Fluticasone furoate is combined with Demecarium.

Fluticasone propionate


The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Demecarium.

Formestane


The risk or severity of adverse effects can be increased when Formestane is combined with Demecarium.

Gallamine Triethiodide


The therapeutic efficacy of Gallamine Triethiodide can be decreased when used in combination with Demecarium.

Glycopyrronium


The therapeutic efficacy of Glycopyrronium can be decreased when used in combination with Demecarium.

Halcinonide


The risk or severity of adverse effects can be increased when Halcinonide is combined with Demecarium.

Halobetasol


The risk or severity of adverse effects can be increased when Ulobetasol is combined with Demecarium.

Homatropine


The therapeutic efficacy of Homatropine can be decreased when used in combination with Demecarium.

Hydrocortisone


The risk or severity of adverse effects can be increased when Hydrocortisone is combined with Demecarium.

Hyoscyamine


The therapeutic efficacy of Hyoscyamine can be decreased when used in combination with Demecarium.

Ipratropium Bromide


The therapeutic efficacy of Ipratropium bromide can be decreased when used in combination with Demecarium.

Ipratropium Bromide Anhydrous


The therapeutic efficacy of Ipratropium bromide can be decreased when used in combination with Demecarium.

Labetalol


Demecarium may increase the bradycardic activities of Labetalol.

Levobunolol


Demecarium may increase the bradycardic activities of Levobunolol.

Lobeline


The risk or severity of adverse effects can be increased when Demecarium is combined with Lobeline.

Loteprednol


The risk or severity of adverse effects can be increased when Loteprednol is combined with Demecarium.

Mecamylamine


The therapeutic efficacy of Mecamylamine can be decreased when used in combination with Demecarium.

Medrysone


The risk or severity of adverse effects can be increased when Medrysone is combined with Demecarium.

Methacholine


The risk or severity of adverse effects can be increased when Demecarium is combined with Methacholine.

Methantheline


The therapeutic efficacy of Methantheline can be decreased when used in combination with Demecarium.

Methixene


The therapeutic efficacy of Metixene can be decreased when used in combination with Demecarium.

Methscopolamine


The therapeutic efficacy of Methscopolamine can be decreased when used in combination with Demecarium.

Methscopolamine Bromide


The therapeutic efficacy of Methylscopolamine bromide can be decreased when used in combination with Demecarium.

Methylprednisolone


The risk or severity of adverse effects can be increased when Methylprednisolone is combined with Demecarium.

Metipranolol


Demecarium may increase the bradycardic activities of Metipranolol.

Metoprolol


Demecarium may increase the bradycardic activities of Metoprolol.

Mivacurium


Demecarium may decrease the neuromuscular blocking activities of Mivacurium.

Mometasone


The risk or severity of adverse effects can be increased when Mometasone is combined with Demecarium.

Nadolol


Demecarium may increase the bradycardic activities of Nadolol.

Nebivolol


Demecarium may increase the bradycardic activities of Nebivolol.

Nicotine


The risk or severity of adverse effects can be increased when Demecarium is combined with Nicotine.

Nicotine Polacrilex


The risk or severity of adverse effects can be increased when Demecarium is combined with Nicotine.

Octotropine Methylbromide


The therapeutic efficacy of Anisotropine Methylbromide can be decreased when used in combination with Demecarium.

Octylonium


The therapeutic efficacy of Otilonium can be decreased when used in combination with Demecarium.

Orphenadrine


The therapeutic efficacy of Orphenadrine can be decreased when used in combination with Demecarium.

Oxitropium


The therapeutic efficacy of Oxitropium can be decreased when used in combination with Demecarium.

Oxprenolol


Demecarium may increase the bradycardic activities of Oxprenolol.

Oxybutynin


The therapeutic efficacy of Oxybutynin can be decreased when used in combination with Demecarium.

Oxyphenonium


The therapeutic efficacy of Oxyphenonium can be decreased when used in combination with Demecarium.

Pancuronium


The therapeutic efficacy of Pancuronium can be decreased when used in combination with Demecarium.

Pancuronium Bromide


The therapeutic efficacy of Pancuronium can be decreased when used in combination with Demecarium.

Paramethasone


The risk or severity of adverse effects can be increased when Paramethasone is combined with Demecarium.

Penbutolol


Demecarium may increase the bradycardic activities of Penbutolol.

Pilocarpine


The risk or severity of adverse effects can be increased when Demecarium is combined with Pilocarpine.

Pindolol


Demecarium may increase the bradycardic activities of Pindolol.

Pipecuronium


The therapeutic efficacy of Pipecuronium can be decreased when used in combination with Demecarium.

Pirenzepine


The therapeutic efficacy of Pirenzepine can be decreased when used in combination with Demecarium.

Practolol


Demecarium may increase the bradycardic activities of Practolol.

Prasterone


The risk or severity of adverse effects can be increased when Prasterone is combined with Demecarium.

Prednicarbate


The risk or severity of adverse effects can be increased when Prednicarbate is combined with Demecarium.

Prednisolone


The risk or severity of adverse effects can be increased when Prednisolone is combined with Demecarium.

Prednisone


The risk or severity of adverse effects can be increased when Prednisone is combined with Demecarium.

Pregnenolone


The risk or severity of adverse effects can be increased when Pregnenolone is combined with Demecarium.

Procyclidine


The therapeutic efficacy of Procyclidine can be decreased when used in combination with Demecarium.

Profenamine


The therapeutic efficacy of Ethopropazine can be decreased when used in combination with Demecarium.

Propantheline


The therapeutic efficacy of Propantheline can be decreased when used in combination with Demecarium.

Propantheline Bromide


The therapeutic efficacy of Propantheline can be decreased when used in combination with Demecarium.

Propiverine


The therapeutic efficacy of Propiverine can be decreased when used in combination with Demecarium.

Propranolol


Demecarium may increase the bradycardic activities of Propranolol.

Quinidine


The therapeutic efficacy of Quinidine can be decreased when used in combination with Demecarium.

Rapacuronium


Demecarium may decrease the neuromuscular blocking activities of Rapacuronium.

Rimexolone


The risk or severity of adverse effects can be increased when Rimexolone is combined with Demecarium.

Scopolamine


The therapeutic efficacy of Scopolamine can be decreased when used in combination with Demecarium.

Scopolamine Hydrobromide


The therapeutic efficacy of Scopolamine can be decreased when used in combination with Demecarium.

Solifenacin


The therapeutic efficacy of Solifenacin can be decreased when used in combination with Demecarium.

Sotalol


Demecarium may increase the bradycardic activities of Sotalol.

Succinylcholine


The serum concentration of Succinylcholine can be increased when it is combined with Demecarium.

Talinolol


Demecarium may increase the bradycardic activities of Talinolol.

Timolol


Demecarium may increase the bradycardic activities of Timolol.

Timolol Anhydrous


Demecarium may increase the bradycardic activities of Timolol.

Tiotropium


The therapeutic efficacy of Tiotropium can be decreased when used in combination with Demecarium.

Tixocortol


The risk or severity of adverse effects can be increased when Tixocortol is combined with Demecarium.

Tolterodine


The therapeutic efficacy of Tolterodine can be decreased when used in combination with Demecarium.

Triamcinolone


The risk or severity of adverse effects can be increased when Triamcinolone is combined with Demecarium.

Trihexyphenidyl


The therapeutic efficacy of Trihexyphenidyl can be decreased when used in combination with Demecarium.

Trihexyphenidyl Hydrochloride


The therapeutic efficacy of Trihexyphenidyl can be decreased when used in combination with Demecarium.

Trimethaphan


The therapeutic efficacy of Trimethaphan can be decreased when used in combination with Demecarium.

Tropicamide


The therapeutic efficacy of Tropicamide can be decreased when used in combination with Demecarium.

Trospium


The therapeutic efficacy of Trospium can be decreased when used in combination with Demecarium.

Tubocurarine


The therapeutic efficacy of Tubocurarine can be decreased when used in combination with Demecarium.

Umeclidinium


The therapeutic efficacy of Umeclidinium can be decreased when used in combination with Demecarium.

Varenicline


The risk or severity of adverse effects can be increased when Demecarium is combined with Varenicline.

Vecuronium


The therapeutic efficacy of Vecuronium can be decreased when used in combination with Demecarium.

Advertisement
Drugs A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Get Health and Wellness Secrets from Our Engaging eBooks
Stay Connected
Available on the Android Market Available on the App Store